Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Might see that 52 week high again!
I like that!
Anyone able to translate what this means?
People need to remove those 8s and she will run over .001
Looking good!
Took a starter!
Sign the petition
https://t.co/RldXeRPHTn
Tweet from NeuroRX 5 minutes ago:
Our CEO Dr. Jonathan Javitt recently sat down with @RfwrightLSL of Life Science Leader and a panel of biopharma CEOs including @PeterDiamandis to discuss #COVID19 technologies in development and our work with #RLF100.
Watch the roundtable: lifescienceleader.com/doc/what-s-hap…
Agreed, it’s been going on for weeks
Nice movement today!
$UPSZ, finally out if 2s, time to move up!
Shorts make those lists or dumb people. It doesn’t matter because of what this is....
This is not a pump and dump. Don’t even go there!
IMO Green Maker does not do scams. I’ve been following him for years. I saw the climb this evening, saw he was posting last week. I will be buying tomorrow. But yes, it is weird how this is trading with the crazy 7 spike today
Most recent is from his brother on Facebook 5 hours ago asking for people to support the blood drive in his honor
The fact that you called out that the website looks like it was made in the 80s has had me laughing non stop. Thanks for the laugh!!! And good post
If anyone like me is wondering what ECMO vs ventilator means:
https://labblog.uofmhealth.org/rounds/when-ventilators-dont-help-covid-19-patients-might
Anyone else ya e this change to numbers in their broker account?
Anyone know why a ticker would change from letters to numbers in my brokerage account? The company had gone out of business a few years ago
Been holding this for awhile, thanks for the info
I agree
You can download the paper that was updated yesterday at the below link:
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3665228
Nice summary, thank you!
$RLFTF power hour, she’s moving!
I know!!!
There some pretty big orders going through in the trades list in just the last 10 minutes....67,000 shares, 29,000, 17,000 shares...volume matters folks
A lot of us are still here...just chillin’ and waiting
Hit send too soon: Update from his brother “The experimental medication has started. Now we wait. In the next 48 hours we will evaluate the progress. Prayers are needed.
Tommy’s medical team has being working around the clock to save his life. I can’t Thank them enough. (Dr. Kumar, Megan Cromwell, Amy, and all the ICU staff). Thank you Memorial Hermann for staffing only the best!”
Having had Covid for 10 weeks, I consider myself lucky to have recovered with minimal after effects. My heart goes out to all families experiencing this.
For those following the firefighter story:
Continued great DD on here. Thanks everyone!!
wondering myself...
Patients in Touch with TrialSite Seeking Help to Access RLF-100 While FDA Approved IND
AUG 16, 2020
"TrialSite News, an online digital media and social engagement platform dedicated to open, accessible, and transparent clinical research, receives messages from patients on a daily basis. With COVID-19, an urgency has raised the stakes of each and every communication. Recently, multiple patients were in touch, asking for TrialSite’s support in a desperate bid to help them figure out how to access RLF-100 for severely ill family members infected with SARS-CoV-2. As in one case, a woman’s husband lies in a San Antonio hospital in critical condition with COVID-19-related breathing problems. On a ventilator, the patient’s wife read TrialSite recently and extended outreach to the team for any suggestions. TrialSite explained the emergency use access concept and suggested she contact her husband’s medical team at the hospital immediately to see if that was available. Additionally, TrialSite sent an email communication to the CEO of NeuroRx Inc., the partner to the actual intellectual property owner, Swiss-based Relief Therapeutics (RELIEF). Why? The wife of the critically ill husband was told of significant success with RLF-100 at Houston Methodist Hospital (TrialSite wrote about this as well). TrialSite did what was possible, given its limitations as a non-medical information intermediary, to help this Texas-based family. The situation isn’t good, but one piece of promising news is that the U.S. Food and Drug Administration (FDA) recently announced that NeuroRx was granted a recently requested Investigational New Drug (IND) application to test RLF-100 (Aviptadil) for inhaled use in patients with moderate to severe COVID-19 in order to prevent progression to respiratory failure. This opens up new potential use cases for this investigational product that shows considerable promise against COVID-19."
This trading makes no sense to me...why people are getting out...scratching my head
Nice find! Tomorrow will be. big day
no kidding, I couldn't help myself - in for more. this is crazy!
there is so much hitting the wires today. Do a search of the latest on Twitter for headlines from today for RLF-100:
"Clinical Trials & Research News Weekly Roundup | FDA: Expanded Access Protocol to RLF-100 for Respiratory Failure for COVID-19"
"Even the patient lying on the ventilator recovered; Researchers say the new drug gives hope"
"Coronavirus: New drug RLF-100 shows dramatic results for critical COVID-19 patients"
"RLF-100 Trial Shows Rapid Recovery From Respiratory Failure in Critically Ill Patients With COVID-19"
...and more...
Relief is in Switzerland, NeuroRx is their US partner. It is normal for companies to partner like this. NeuroRx however is privately owned, so no stock option...Relief is publicly traded and holds the patent on Aviptadil. I doubt there is anyway to find out what compensation by group looks like...but probably more in Reliefs corner since they can raise funds and have the patent. This is beyond my knowledge, I am speculating...
About RELIEF THERAPEUTICS Holding AG
The Relief group of companies focus primarily on clinical-stage projects based on molecules of natural origin (peptides and proteins) with a history of clinical testing and use in human patients or a strong scientific rationale. Currently, Relief is concentrating its efforts on developing new treatments for respiratory disease indications.
Relief Therapeutics holds orphan drug designations from the U.S. Food and Drug Administration and the European Union for the use of VIP to treat ARDS, pulmonary hypertension, and sarcoidosis. Relief Therapeutics also holds a U.S. patent (US8178489 formulation for aviptadil) for RLF-100 and proprietary manufacturing processes for its synthesis.
RELIEF THERAPEUTICS Holding AG is listed on the SIX Swiss Exchange under the symbol RLF.
About NeuroRx, Inc.
NeuroRx draws upon more than 100 years of collective drug development experience and is led by former senior executives of Johnson & Johnson, Eli Lilly, Pfizer, and AstraZeneca, PPD. In addition to its work on RLF-100, NeuroRx has been awarded Breakthrough Therapy Designation and a Special Protocol Agreement to develop NRX-101 for the treatment of suicidal bipolar depression and is currently in Phase 3 trials. Its Board of Directors and Advisors includes Hon. Sherry Glied, former Assistant Secretary, U.S. Dept. of Health and Human Services; Mr. Chaim Hurvitz, former President of the Teva International Group, Lt. Gen. HR McMaster, the 23rd National Security Advisor, Wayne Pines, former Associate Commissioner of the U.S. Food and Drug Administration, Judge Abraham Sofaer, and Daniel Troy, former Chief Counsel, U.S. Food and Drug Administration.
There are two pathways here.
1) The Houston team proved that use of RLF-1000 in very ill patients could bring them off of respirators. "54-year-old man being treated for rejection of a double lung transplant was able to come off ventilator-assisted breathing within 4 four days of care." they have a total of 25 patients at that facility on the treatment
2) The FDA then invited NeuroRx to do a study to see if RLF-100 had an effect on those who have not gone into respiratory failure yet. They literally where just asked to do this study in the last 7 days. So they don't have patient enrolled yet. You have to pick a site for the trial, set a protocol, do recruitment....patience here
There is more to it than that.
There is a group of 25 that were already underway in Houston, we should hear more on those beyond the 6 next week IMO. And the FDA just invited them to do a trial on patients who are not already in respiratory failure. That is a big deal and not common place.
I also had COVID-19 and was hospitalized and sent home on Oxygen, I know how long it took for my blood ox to come up and to get a clear X-Ray, it wasn't 6 days. I fought the virus for 11 weeks!
"Dr. George Youssef and his colleagues have shown already six patients, but they have more than 25 in this compassionate care program where chest X-rays have cleared within days of treatment, and that's just not commonly seen with COVID," said Javitt.
NeuroRx learned on Thursday that the FDA has invited them to do a trial for the inhaled version of the treatment. It would be for patients who are not nearly as sick.
The treatment would target "patients who have COVID but haven't yet developed respiratory failure, in the hopes that we can prevent them from developing respiratory failure," said Javitt.
https://abc13.com/treatment-for-covid-19-coronavirus-houston-methodist-hospital-how-to-treat/6357769/